105
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Determination of heavy metals and risk assessment in nail cosmetics sold in Seoul, Korea

, , &
Pages 131-136 | Received 10 Jan 2022, Accepted 05 Jun 2023, Published online: 22 Jun 2023
 

Abstract

Objective

The objective of this study was to evaluate some toxic levels of nail cosmetics marketed in Seoul, Korea and health risk assessment on humans.

Methods

We collected 45 random nail cosmetics and analysed for lead, cadmium, arsenic and antimony by inductively coupled plasma-optical emission spectrometry (ICP-OES).

Results

Four metals concentrations were Pb 0.037 ± 0.083 (<LOD ∼ 0.322) mg/kg, Cd 0.021 ± 0.058 (<LOD ∼ 0.342) mg/kg, As 0.094 ± 0.278 (<LOD ∼ 1.696) mg/kg and Sb 6.75 ± 17.54 (<LOD ∼ 59.017) mg/kg respectively. The concentrations of antimony were significantly higher than other metal concentrations (p < 0.05) and Sb concentrations in 6 samples were above the acceptable limits in Korea. As the result of the health risk assessment, MoS, HQ and HI values for Pb, As and Cd were within the permissible limit, but outside the acceptable range of Sb. LCR value was lower than the allowed limit for all nail cosmetics.

Discussion and conclusion

Six nail cosmetics had high antimony concentrations which were higher than the current legal limit in Korea. Because of 6 high antimony concentrations, MoS, HQ and HI were outside the acceptable range. LCR value for Pb, As and Cd was below 1 0 −6 which was lower than the permissible limit and nail cosmetics may not possess lifetime cancer risk. Our results suggested that metals were present in nail cosmetics at diverse concentrations and some nail cosmetics appeared to pose a harmful impact on health.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.